Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.01
-
Shares outstanding
-
27,407,170
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
12,690,783
-
Shares change
-
+1,349,365
-
Total reported value, excl. options
-
$269,235,332
-
Value change
-
+$30,861,412
-
Number of buys
-
38
-
Number of sells
-
-42
-
Price
-
$21.22
Significant Holders of ICAD, INC. - Common Stock, par value $0.01 (ICAD) as of Q1 2021
100 filings reported holding ICAD - ICAD, INC. - Common Stock, par value $0.01 as of Q1 2021.
ICAD, INC. - Common Stock, par value $0.01 (ICAD) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12,690,783 shares
of 27,407,170 outstanding shares and own 46.3% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,402,505 shares), VANGUARD GROUP INC (1,140,761 shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (928,010 shares), Portolan Capital Management, LLC (892,005 shares), G2 Investment Partners Management LLC (746,508 shares), FEDERATED HERMES, INC. (707,053 shares), Parkman Healthcare Partners LLC (648,131 shares), WELLINGTON MANAGEMENT GROUP LLP (429,595 shares), PURA VIDA INVESTMENTS, LLC (388,193 shares), and GEODE CAPITAL MANAGEMENT, LLC (343,124 shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.